Science 37 Holdings Inc (SNCE) Quote

Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial

RESEARCH TRIANGLE PARK, N.C., May 02, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. today disclosed the latest enrollment figures resulting from its Metasite™ and Patient Recruitment...

Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment

RESEARCH TRIANGLE PARK, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc., the clinical research industry’s leading MetasiteTM, today announced the launch of a stand-alone...

eMed completes tender offer for all outstanding shares of Science 37

eMed completes tender offer for all outstanding shares of Science 37 PR Newswire MIAMI, March 12, 2024 MIAMI, March 12, 2024 /PRNewswire/ -- eMed, LLC ("eMed") today announced the successful...

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Kuehn Law Encourages DFS, SNCE, HRT, and IONM Investors to Contact Law Firm

Kuehn Law Encourages DFS, SNCE, HRT, and IONM Investors to Contact Law Firm PR Newswire NEW YORK, Feb. 19, 2024 NEW YORK, Feb. 19, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation...

Form SC 14D9 - Solicitation, recommendation statements

Form SC TO-T - Tender offer statement by Third Party

eMed commences tender offer for Science 37

eMed commences tender offer for Science 37 PR Newswire MIAMI, Feb. 12, 2024 MIAMI, Feb. 12, 2024 /PRNewswire/ -- eMed, LLC ("eMed") today announced that its wholly-owned subsidiary, Marlin Merger...

Form SC14D9C - Written communication relating to third party tender offer